Keio University and affiliated hospitals have established an observational COPD cohort designed to prospectively investigate the management of COPD comorbidities. A total of 572 subjects were enrolled between April 2010 and December 2012, including patients who had been diagnosed as having COPD and at risk for COPD (non-COPD) by pulmonary physicians. Inclusion criteria consisted of (1) age≧40 years old, (2) forced expiratory volume in one second (FEV1)/forced vital capacity (FVC) < 0.7, (3) presence of emphysematous changes on chest computed tomography (CT) scans, and (4) chronic respiratory symptoms with significant smoking history (≧30 pack-years). Pulmonary function tests and chest CT scan were performed in all participants, and the COPD group fulfilled the criteria (1) and (2), while the non-COPD group met the criteria (1) and either (3) or (4) without airflow limitation (FEV1/FVC≧0.7). Excluded were patients who had a history of lung resection surgery or serious complications such as unstable cardiovascular or cerebral diseases and malignant tumors under treatment. For the purpose of this study, only subjects with complete data available for comorbidities (n = 403) were enrolled. All patients were clinically stable and without exacerbations for at least one month prior to recruitment. The protocol was approved by the ethics committees of Keio University and the affiliated hospitals, and written, informed consent was obtained from each patient.
Free full text: Click here